| Name | (2-methyl-6-nitro-3H-imidazo[2,1-b][1,3]oxazol-2-yl)methanol |
|---|---|
| Synonyms |
(R)-(2-Methyl-6-nitro-2,3-dihydro-imidazo[2,1
(2-METHYL-6-NITRO-2,3-DIHYDRO-IMIDAZO[2,1-B]OXAZOL-2-YL)-METHANOL 2-hydroxymethyl-2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazole (2-methyl-6-nitro-3H-imidazo[2,1-b]oxazol-2-yl)methanol (2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b][1,3]oxazol-2-yl)methanol |
| Density | 1.69g/cm3 |
|---|---|
| Boiling Point | 400.7ºC at 760 mmHg |
| Molecular Formula | C7H9N3O4 |
| Molecular Weight | 199.16400 |
| Flash Point | 196.1ºC |
| Exact Mass | 199.05900 |
| PSA | 93.10000 |
| LogP | 0.45790 |
| Index of Refraction | 1.691 |
| HS Code | 2934999090 |
|---|
|
~94%
681491-12-3 |
| Literature: Global Alliance for TB Drug Development Patent: US2011/28466 A1, 2011 ; Location in patent: Page/Page column 14 ; |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |